Dr Reddy’s Laboratories partners with Sanofi to introduce Beyfortus, a groundbreaking RSV drug, in India. Approved globally and now in India, it aims to protect infants from severe...
European markets anticipate a lower opening as investors digest mixed first-quarter earnings. BNP Paribas and Sanofi report strong revenue growth, while Renault and Eni face declin...
European markets anticipate a lower open as Q1 earnings reveal a mix of growth and declines among major firms like BNP Paribas, Sanofi, Roche, Nestle, Renault, and Eni, with curren...
European markets anticipate a mostly lower opening as investors react to mixed Q1 earnings. BNP Paribas and Sanofi report strong revenue growth, while Renault and Eni see declines....
European markets anticipate a lower open as Q1 earnings show a mixed bag of results. BNP Paribas and Sanofi lead with significant revenue growth, while Renault and Eni report decli...
European markets anticipate a lower opening as investors digest mixed first-quarter earnings. BNP Paribas and Sanofi report strong revenue growth, while Renault and Eni face declin...
European markets anticipate a mostly lower opening as Q1 earnings reports show mixed results. BNP Paribas and Sanofi lead with significant revenue increases, while Renault and Eni ...
European markets anticipate a lower opening as Q1 earnings reports present a mixed picture, with BNP Paribas and Sanofi leading gains while Renault and Eni report declines. Key ind...
European markets anticipate a mostly lower open as Q1 earnings reveal mixed results. BNP Paribas and Sanofi report strong gains, while Renault and Eni face declines. Currency marke...
European markets anticipate a lower opening as investors review mixed Q1 earnings. BNP Paribas and Sanofi report strong revenue growth, while Renault and Eni see declines. Key indi...
European markets are anticipated to open lower as mixed Q1 earnings reports come in. BNP Paribas and Sanofi show strong revenue growth, while Renault and Eni report declines. Curre...
Novartis and Sanofi CEOs have urged the EU to increase drug prices, warning of the region's pharmaceutical sector decline. They propose measures like EU-wide list prices and spendi...
European pharmaceutical stocks, including Sanofi, GSK, AstraZeneca, Roche, and Novartis, declined after US President Trump announced plans for major tariffs on pharmaceuticals, rai...
Following US President Donald Trump's announcement of major tariffs on pharmaceuticals, European pharmaceutical stocks, including Sanofi, GSK, AstraZeneca, Roche, and Novartis, exp...
Following President Trump's announcement of a major tariff on pharmaceuticals, leading European pharmaceutical companies experienced significant stock declines, highlighting invest...
Following President Trump's announcement of a major tariff on pharmaceuticals, European pharma stocks, including Novartis, Roche, Sanofi, AstraZeneca, and GSK, experienced signific...
Following President Trump's announcement of major tariffs on pharmaceuticals, European pharmaceutical stocks, including Novartis, Roche, Sanofi, AstraZeneca, and GSK, experienced s...
European stock indexes trended positively ahead of the ECB's rate decision, with a 25 basis points cut expected. Deutsche Bank, F. Hoffmann-La Roche, and Sanofi released earnings, ...
